Abstract
The number of publications related to immunity and diabetic nephropathy (DN) has increased annually over the past 20 years, with a significant increase in the last 3 years especially. Our results identified research hotspots and trends in the field. These findings provide valuable perspectives for future research, enhancing our understanding of the immune-related mechanisms of DN and exploring potential therapeutic strategies.
Introduction
Diabetic nephropathy (DN) is the primary driver of end-stage renal disease (ESRD) worldwide. For decades, clinical focus remained locked on managing blood glucose and blood pressure. However, even when these factors are controlled, many patients still progress toward kidney failure. This suggests that other underlying mechanisms—specifically the immune system—play a critical role in the disease's progression.
While thousands of papers have explored the "immune-DN" link, the field has become so vast that it is difficult for researchers to identify overarching trends, dominant contributors, or emerging "hotspots." This paper addresses this gap by using bibliometric analysis to synthesize 20 years of data into a visual and quantitative roadmap.
Methodology
The researchers used the Web of Science Core Collection (WoSCC) as their primary data source, retrieving 1,246 relevant publications (838 original articles and 408 reviews) published between 2004 and 2023. Analysis was conducted using two distinct software packages:
- VOSviewer: Used to create distance-based visualizations to identify clusters of collaboration between countries, institutions, and journals.
- CiteSpace: Used for timeline and "burst" analysis to identify periods where specific keywords or papers received sudden, intense attention.
Global Research Trends and Evolution
Research in this field has evolved through three distinct phases: a "stagnant period" (2004–2008), a "slow-growth period" (2009–2013), and a "rapid growth period" (2014–present). We are currently in a peak of interest, with over 120 papers published annually since 2021.
Geographically, China and the USA are the dominant players. China leads the world in total publication volume (34.91% of papers), while the USA maintains a significantly higher total citation count (18,161). Interestingly, England holds the highest "quality" metric with an average of 92.32 citations per paper, suggesting that while they produce fewer papers, their contributions are highly influential.
Key Insights and Hotspots
The keyword analysis reveals a clear transition in research focus. Early research was preoccupied with general hyperglycemia and chemokines. The field then moved into Toll-like receptors and macrophages. The current "cutting edge" has shifted toward ferroptosis (iron-dependent programmed cell death) and lipid metabolism, suggesting these are the most promising areas for future therapeutic targets.
In terms of institutional influence, the University of California System is the most prolific, while Kidney International remains the "gold standard" for highly-cited, foundational research. The article "Innate immunity in diabetic kidney disease" by Tang SCW (published in Nature Reviews Nephrology) stands as the most co-cited reference in the field.
Conclusion and Future Directions
While this study provides a comprehensive overview, it is limited by its reliance on a single database (WoSCC) and English-language publications. Future research is expected to focus on the "triple threat" of immune-related inflammation, the specific pathways of ferroptosis in renal tubular cells, and how lipid microenvironments dictate immune cell behavior within the kidney. These findings provide valuable perspectives for enhancing our understanding of DN and exploring potential therapeutic strategies.
Summary updated